Diadexus (DDXS) Stock Price, News & Analysis

Company Overview

Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 30 shs
• Average Volume: 15,481 shs
• Market Capitalization: $53 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DDXS Stock Analysis - Frequently Asked Questions

How were Diadexus' earnings last quarter?

Diadexus, Inc. (OTCMKTS:DDXS) posted its quarterly earnings results on Monday, October, 26th. The company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.69) by $0.35.

How do I buy shares of Diadexus?

Shares of DDXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Diadexus own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Diadexus investors own include GoPro (GPRO), GE Aerospace (GE), Ambarella (AMBA) and Alliqua Biomedical (ALQA).

Company Calendar

• Last Earnings: 10/26/2015
• Today: 8/23/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:DDXS
• CIK: 1036968
• Web: www.diadexus.com
• Phone: (650) 246-6400
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,100,000
• Free Float: N/A
• Market Cap: $53 thousand
• Optionable: Not Optionable
• Beta: N/A